Strengthening the status of psychotherapy for personality disorders: An integrated perspective on effects and costs

Canadian Journal of Psychiatry

Volumn 52, Issue 12, 2007, Pages 803-810

  Bartak, Anna ^a,c   Soeteman, Djøra I ^b,c   Verheul, Roel ^a,c   Busschbach, Jan J V ^b,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Viersprong Institute for Studies on Personality Disorders   (Netherlands)

Author keywords

Burden of illness; Cost effectiveness; Health care costs; Personality disorders; Program evaluation; Psychotherapy; Treatment efficacy; Treatment outcome

Indexed keywords

COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HUMAN; PERSONALITY DISORDER; PSYCHOTHERAPY; REVIEW;

EID: 37749039310     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370705201208     Document Type: Review

References (56)

1. Leichsenring F, Leibing E. The effectiveness of psychodynamic therapy and cognitive behavior therapy in the treatment of personality disorders: a meta-analysis. Am J Psychiatry. 2003;160(7):1223-1232.
2. Russell LB, Gold MR, Siegel JE, et al. The role of cost-effectiveness analysis in health and medicine. JAMA. 1996;276(14):1172-1177.
3. Rutten F, Brouwer W, Niessen L. Practice guidelines based on clinical and economic evidence: indispensable tools in future market oriented health care. Eur J Health Econ. 2005;6(2):91-93.
4. Bateman AW, Fonagy P. Effectiveness of psychotherapeutic treatment of personality disorder. Br J Psychiatry. 2000;177:138 -143.
5. Gabbard GO. Psychotherapy of personality disorders. J Psychother Pract Res. 2000;9(1):1-6.
6. Ogrodniczuk JS, Piper WE. Day treatment for personality disorders: a review of research findings. Harv Rev Psychiatry. 2001;9(3):105-117.
7. Perry JC, Banon E, Ianni F. Effectiveness of psychotherapy for personality disorders. Am J Psychiatry. 1999;156(9):1312-1321.
8. Perry JC, Bond M. Empirical studies of psychotherapy for personality disorders. In: Gunderson JG, Gabbard GO. Psychotherapy for personality disorders. Review of psychiatry. Washington (DC): American Psychiatric Publishing; 2000. 1-31.
9. Sanislow CA, McGlashan TH. Treatment outcome of personality disorders. Can J Psychiatry. 1998;43(3):237-250.
10. Shea MT. Psychosocial treatment of personality-disorders. J Personal Disord. 1993;7:167-180.
11. Binks CA, Fenton M, McCarthy L, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2006(1):CD005652.
12. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale (NJ): Lawrence Erlbaum Associates Inc; 1977.
13. Turner RM. Naturalistic evaluation of dialectical behavior therapy-oriented treatment for borderline personality disorder. Cogn Behav Pract. 2000;7(4):413-419.
14. Koons CR, Robins CJ, Tweed JL, et al. Efficacy of dialectical behavior therapy in women veterans with borderline personality disorder. Behav Ther. 2001;32(2):371-390.
15. Verheul R, Van Den Bosch LM, Koeter MW, et al. Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands. Br J Psychiatry. 2003;182:135-140.
16. Brown GK, Newman CF, Charlesworth SE, et al. An open clinical trial of cognitive therapy for borderline personality disorder. J Personal Disord. 2004;18(3):257-271.
17. Chiesa M, Fonagy P, Holmes J, et al. Residential versus community treatment of personality disorders: a comparative study of three treatment programs. Am J Psychiatry. 2004;161(8):1463-1470.
18. Svartberg M, Stiles TC, Seltzer MH. Randomized, controlled trial of the effectiveness of short-term dynamic psychotherapy and cognitive therapy for cluster C personality disorders. Am J Psychiatry. 2004;161(5):810-817.
19. Giesen-Bloo J, Van Dyck R, Spinhoven P, et al. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry. 2006;63(6):649-658.
20. Emmelkamp PM, Benner A, Kuipers A, et al. Comparison of brief dynamic and cognitive-behavioural therapies in avoidant personality disorder. Br J Psychiatry. 2006;189:60-64.
21. Huband N, McMurran M, Evans C, et al. Social problem-solving plus psychoeducation for adults with personality disorder: pragmatic randomised controlled trial. Br J Psychiatry. 2007;190:307-313.
22. Bateman A, Fonagy P. Health service utilization costs for borderline personality disorder patients treated with psychoanalytically oriented partial hospitalization versus general psychiatric care. Am J Psychiatry. 2003;160(1):169-171.
23. Hall J, Caleo S, Stevenson J, et al. An economic analysis of psychotherapy for borderline personality disorder patients. J Ment Health Policy Econ. 2001;4(1):3-8.
24. Stevenson J, Meares R. Psychotherapy with borderline patients: II. A preliminary cost benefit study. Aust N Z J Psychiatry. 1999;33(4):473-477; discussion 478-481.
25. Dolan BM, Warren FM, Menzies D, et al. Cost-offset following specialist treatment of severe personality disorders. Psych Bull. 1996;20:413-417.
26. Gabbard GO, Lazar SG, Hornberger J, et al. The economic impact of psychotherapy: a review. Am J Psychiatry. 1997;154(2):147-155.
27. Stevenson J, Meares R. An outcome study of psychotherapy for patients with borderline personality disorder. Am J Psychiatry. 1992;149(3):358-362.
28. Stolk EA, Brouwer WBF, Busschbach JJV. Rationalising rationing: economic and other considerations in the debate about funding of Viagra. Health Policy. 2002;59(1):53-63.
29. Schofield W. Psychotherapy: the purchase of friendship. Englewood Cliffs (NJ): Prentice Hall; 1964.
30. Stolk EA, Pickee SJ, Ament AH, et al. Equity in health care prioritisation: an empirical inquiry into social value. Health Policy. 2005;74(3):343-355.
31. Brooks R, Rabin R. The measurement and valuation of health status using EQ-5D: a European perspective evidence from the EuroQol BIOMED Research Programme. Dordrecht (NL): Kluwer Academic Publishers; 2003.
32. Soeteman DI, Timman R, Trijsburg RW, et al. Assessment of the burden of disease among inpatients in specialized units that provide psychotherapy. Psychiatr Serv. 2005;56(9):1153-1155.
33. Soeteman DI, Verheul R, Busschbach JJV. The burden of disease in personality disorders: diagnosis-specific quality of life. J Personal Disord. Forthcoming 2007.
34. Nakao K, Gunderson JG, Phillips KA. Functional impairment in personality disorders. J Personal Disord. 1992;6(1):24-33.
35. Skodol AE, Gunderson JG, McGlashan TH, et al. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Am J Psychiatry. 2002;159(2):276-283.
36. Hueston WJ, Mainous AGr, Schilling R. Patients with personality disorders: functional status, health care utilization, and satisfaction with care. J Fam Pract. 1996;42(1):54-60.
37. Abrams RC, Alexopoulos GS, Spielman LA, et al. Personality disorder symptoms predict declines in global functioning and quality of life in elderly depressed patients. Am J Geriatr Psychiatry. 2001;9(1):67-71.
38. Hays RD, Wells KB, Sherbourne CD, et al. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry. 1995;52(1):11-19.
39. Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA. 1989;262(7):914-919.
40. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington (DC): American Psychiatric Publishing Inc; 1994.
41. Verheul R, Kranzler HR, Poling J, et al. Co-occurrence of axis I and axis II disorders in substance abusers. Acta Psychiatr Scand. 2000;101:110-118.
42. Haynes B. Can it work? Does it work? Is it worth it? The testing of healthcare interventions is evolving. BMJ. 1999;319(7211):652-653.
43. Wells KB. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry. 1999;156(1):5-10.
44. Emmelkamp PM. Author's reply. Br J Psychiatry. 2007;190:80-81.
45. Hoglend P. Personality-disorders and long-term outcome after brief dynamic psychotherapy. J Personal Disord. 1993;7(2):168-181.
46. Howard KI, Kopta SM, Krause MS, et al. The dose-effect relationship in psychotherapy. Am Psychol. 1986;41(2):159-164.
47. Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry. 1999;156(10):1563-1569.
48. Bateman A, Fonagy P. Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. Am J Psychiatry. 2001;158(1):36-42.
49. Beecham J, Sleed M, Knapp M, et al. The costs and effectiveness of two psychosocial treatment programmes for personality disorder: a controlled study. Eur Psychiatry. 2006;21(2):102-109.
50. Martin DJ, Garske JP, Davis MK. Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review. J Consult Clin Psychol. 2000;68(3):438-450.
51. Castonguay LG, Beutler LE. Principles of therapeutic change that work. New York (NY): Oxford University Press; 2006.
52. Spiegel D. Efficacy and cost-effectiveness of psychotherapy. Washington (DC): American Psychiatric Publishing Inc; 1999.
53. Miller NE, Magruder KM. Cost-effectiveness of psychotherapy: a guide for practitioners, researchers, and policymakers. New York (NY): Oxford University Press; 1999.
54. Brazier J, Tumur I, Holmes M, et al. Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation. Health Technol Assess. 2006;10(35):iii, ix-xii, 1-117.
55. Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economical evaluation of health care programmes. 3rd ed. Oxford (GB): Oxford University Press; 2005.
56. Aronsson G, Gustafsson K, Dallner M. Sick but yet at work. An empirical study of sickness presenteeism. J Epidemiol Community Health. 2000;54(7):502-509.